Conference Details - Abstract

View all Conferences

Continuing Education Information

Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credit

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.

Eighth International Congress on Targeted Therapies in Cancer

Renaissance Mayflower Hotel
Washington, DC
August 21-23, 2009

Abstract Submission Instructions

The Eighth International Congress on Targeted Therapies in Cancer is accepting abstracts for consideration for poster presentations.

Deadline for submission is July 24, 2009.

Abstracts must be e-mailed as a Word document to info@cancerlearning.com.

$100.00 Discounted Registration Fee for Accepted Poster Submissions

Instructions for submitting an abstract:

  • Submissions are accepted as a Word document via e-mail only.
  • Include the key contact information for the abstract in the e-mail:
    • Name and credentials
    • Title
    • Organization
    • Specialty
    • Address
    • City, state/province, postal code, and country
    • Phone, fax, and e-mail address
  • Underline the presenter of the paper, and spell out the complete name of each author.
  • List city, state, country, and institution of origin.

One week after the close of submissions, you will receive notification of the acceptance or nonacceptance of the abstract.

Upon acceptance, you will be provided specific information on the preparation of the abstract as a poster as well as the date and times of the poster session.

Accepted abstracts will be published in the program material.

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech BioOncology
  2. Amgen
  3. Merck Oncology
  4. sanofi-aventis U.S.
  5. Wyeth Pharmaceuticals
  6. Novartis Oncology
  7. ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
  8. OSI Oncology